New catheter aims to drain fluid in stubborn heart failure cases

NCT ID NCT05206422

First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 2 times

Summary

This study tests a new device called the Doraya Catheter for people hospitalized with acute heart failure who still have too much fluid in their body even after taking water pills (diuretics). The catheter is designed to help remove the excess fluid. The study includes 30 adults with signs of fluid overload and will check if the device is safe and works well.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE DECOMPENSATED HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Baylor University Medical Center

    Dallas, Texas, 75246, United States

  • CHI St. Luke's Health-Baylor St. Luke's Medical Center

    Houston, Texas, 77030, United States

  • Christian Hospital

    St Louis, Missouri, 63136, United States

  • Cleveland Clinic

    Weston, Florida, 33331, United States

  • Northeast Georgia Medical Center

    Gainesville, Georgia, 30501, United States

  • Oklahoma Heart

    Oklahoma City, Oklahoma, 73135, United States

  • Piedmont Hospital

    Augusta, Georgia, 30901, United States

  • Prisma Health

    Columbia, South Carolina, 29203, United States

  • San Francisco VA

    San Francisco, California, 94121, United States

  • The Christ Hospital

    Cincinnati, Ohio, 45219, United States

  • The MetroHealth System

    Cleveland, Ohio, 44109, United States

  • The Ohio State University

    Columbus, Ohio, 43210, United States

  • UCSF

    San Francisco, California, 94143, United States

  • Zuckerberg San Francisco General

    San Francisco, California, 94110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.